Amelie Erben from Hyperganic Group joins Adam Penna on this episode of the AM Voices podcast to discuss the current state of bioprinting and applying the rules of nature to algorithms that shape the future of additive manufacturing.
Amelie covers what can be leveraged by creating cell structures at the voxel level to create functional tissues in the actual bioprinting process. She goes through the entire process from design, materials, and simulation, to final application.
Available in your favorite app:
related /
EOS and Hyperganic Group Team Up to Elevate the Design and Performance of Space Propulsion Components
MeaTech has Developed a Unique Multi-Nozzle 3D Bioprinting System for Highly Precise Industrial Scale Production of Cultured Meat Products
Essent Biologics Launches Micronized Bone Matrix for 3D Bioprinting and Tissue Engineering Applications
